natgillin/translations-raw huggingface dataset:
It is recommended that all patients, including children, avoid exposure to direct sunlight during Voriconazole Accord treatment and use measures such as protective clothing and sunscreen with high sun protection factor (SPF).
Priporočljivo je, da se vsi bolniki, vključno z otroci, med zdravljenjem z zdravilom Vorikonazol Accord izogibajo izpostavljenosti neposredni sončni svetlobi in po potrebi sledijo ukrepom, kot so zaščitna oblačila in krema za zaščito pred soncem z visokim zaščitnim faktorjem.
It is recommended that all patients, including children, avoid exposure to direct sunlight during Voriconazole Hospira treatment and use measures such as protective clothing and sunscreen with high sun protection factor (SPF).
Priporočljivo je, da se vsi bolniki, vključno z otroci, med zdravljenjem z zdravilom Vorikonazol Hospira izogibajo izpostavljenosti neposredni sončni svetlobi in sledijo ukrepom, kot so zaščitna oblačila in krema za zaščito pred soncem z visokim zaščitnim faktorjem.
It is recommended that alternative administration forms should be considered for concomitant treatment of concurrent diseases that can be treated via nasal administration.
V primeru sočasnega zdravljenja spremljajočih bolezni, ki se lahko zdravijo z nazalnim vnosom, je priporočljivo razmisliti o alternativnih načinih vnosa teh zdravil.
It is recommended that Ambirix should be administered in settings where completion of the two-dose vaccination course can be assured.
Ambirix je priporočljivo dajati v okoliščinah, ki zagotavljajo dokončanje cepljenja z dvema odmerkoma.
It is recommended that AMMONAPS granules are used instead.
Priporočamo jemanje zdravila AMMONAPS zrnca.
It is recommended that animals are fasted for 12 hours prior to administration.
Priporočeno je, da živali postijo 12 ur pred uporabo zdravila.
It is recommended that animals are fasted for 12 hours prior to Sedadex administration.
Priporočeno je postenje živali 12 ur pred dajanjem zdravila Sedadex.
It is recommended that antihistamine medicinal product be repeated every 4–6 hours as required during infusion of Unituxin.
Priporoča se, da se dajanje antihistaminika ponovi vsakih 4—6 ur, kot je zahtevano med infuzijo zdravila Unituxin.
It is recommended that any additional pathology be investigated and treated appropriately.
Vsako dodatno patologijo je priporočljivo raziskati in ustrezno zdraviti.
It is recommended that Atripla be taken on an empty stomach, preferably at bedtime.
Priporočljivo je, da se zdravilo Atripla jemlje na prazen želodec, po možnosti pred spanjem.
It is recommended that blood pressure is measured periodically in patients over 65 years.
Kot pri drugih antipsihotikih je priporočeno redno merjenje krvnega tlaka pri bolnikih, starejših od 65 let.
It is recommended that blood pressure is measured periodically in patients over 65 years.
Priporočeno redno merjenje krvnega tlaka pri bolnikih, starejših od 65 let.
It is recommended that cats and ferrets living in, or travelling to areas endemic for heartworm are treated monthly with the product to protect them from heartworm disease.
Mačke in bele dihurje, ki živijo ali potujejo na področja, ki so infestirana z Dirofilario immitis, zdravimo enkrat mesečno.
It is recommended that cats and ferrets living in, or travelling to, areas endemic for heartworm are treated monthly with the product to protect them from heartworm disease.
Mačke in bele dihurje, ki živijo ali potujejo na področja, ki so infestirana z Dirofilario immitis zdravimo enkrat mesečno.
It is recommended that CellCept 1 g/5 ml powder for oral suspension be reconstituted by the pharmacist prior to dispensing to the patient.
Priporočljivo je, da zdravilo CellCept 1 g/5 ml prašek za peroralno suspenzijo pred izdajo zdravila bolniku raztopi farmacevt.
It is recommended that chemotherapy not be added to treatment with steroids since there is no experience with administration of both steroids and chemotherapy during treatment of the leukocyte activation syndrome due to TRISENOX.
Priporočamo, da med zdravljenjem s steroidi ne začnete kemoterapije, kajti nimamo izkušenj s skupno uporabo steroidov in kemoterapije med zdravljenjem sindroma aktivacije levkocitov, do katerega pride zaradi zdravila TRISENOX.
It is recommended that CKD patients not on dialysis are given vitamin D supplements (approximately 400 IU of native vitamin D daily) which can be part of a multivitamin preparation to be taken apart from their dose of Renvela.
Priporoča se, da bolniki s KBL, ki niso na dializi, dobivajo nadomestke vitamina D (približno 400 i.e. naravnega vitamina D na dan), kar je lahko del multivitaminskega pripravka, ki ga bilniki jemljejo poleg odmerka zdravila Renvela.
It is recommended that CKD patients not on dialysis are given vitamin D supplements (approximately 400 IU of native vitamin D daily) which can be part of a multivitamin preparation to be taken apart from their dose of Renvela.
Priporoča se, da bolniki s KBL, ki niso na dializi, dobivajo nadomestke vitamina D (približno 400 i.e. naravnega vitamina D na dan), kar je lahko del multivitaminskega pripravka, ki ga bolniki jemljejo poleg odmerka zdravila Renvela.
It is recommended that CKD patients not on dialysis are given vitamin D supplements (approximately 400 IU of native vitamin D daily) which can be part of a multivitamin preparation to be taken apart from their dose of Renvela.
Priporoča se, da bolniki s KBL, ki niso na dializi, dobivajo nadomestke vitamina D (približno 400 i.e. nativnega vitamina D na dan), kar je lahko del multivitaminskega pripravka, ki ga bolniki jemljejo poleg odmerka zdravila Renvela.
It is recommended that CKD patients not on dialysis are given vitamin D supplements (approximately 400 IU of native vitamin D daily) which can be part of a multivitamin preparation to be taken apart from their dose of Sevelamer carbonate Zentiva.
Priporoča se, da bolniki s KBL, ki niso na dializi, dobivajo nadomestke vitamina D (približno 400 i.e. naravnega vitamina D na dan), kar je lahko del multivitaminskega pripravka, ki ga bolniki jemljejo poleg odmerka zdravila Sevelamer carbonate Zentiva.
It is recommended that Clomicalm be administered to dogs with cardiovascular dysfunction or epilepsy with caution and only after an assessment of the benefit risk ratio.
Pred dajanju zdravila psom, ki imajo motnje v delovanju kardiovaskularnega sistema ali epilepsijo, je potrebno oceniti razmerje med tveganjem in koristjo uporabe zdravila Clomicalm.
It is recommended that Clomicalm be administered to dogs with cardiovascular dysfunction or epilepsy with caution and only after an assessment of the benefit risk ratio.
Priporočljivo je, da pri psih, ki imajo motnje v delovanju kardiovaskularnega sistema ali epilepsijo, pred uporabo ocenite razmerje tveganja in koristi pri uporabi zdravila Clomicalm.
It is recommended that concomitant use of nasal decongestants is avoided (see section 5.2)
Priporočljivo se je izogibati sočasni uporabi nosnih dekongestivov (glejte poglavje 5.2).
It is recommended that creatinine clearance is calculated in all patients prior to initiating therapy with adefovir dipivoxil and that renal function (creatinine clearance and serum phosphate) be monitored every four weeks during the first year and then every three months thereafter.
Pred začetkom zdravljenja z dipivoksiladefoviratom se priporoča določiti očistek kreatinina pri vseh bolnikih in spremljanje ledvične funkcije (očistek kreatinina in koncentracija fosfata v serumu) vsake 4 tedne v prvem letu in nato vsake tri mesece.
It is recommended that creatinine clearance is calculated in all patients prior to initiating therapy with Eviplera and renal function (creatinine clearance and serum phosphate) is also monitored after two to four weeks of treatment, after three months of treatment and every three to six months thereafter in patients without renal risk factors.
Pred začetkom zdravljenja z zdravilom Eviplera se priporoča izračun očistka kreatinina pri vseh bolnikih in nadzor delovanja ledvic (očistek kreatinina in vrednost serumskega fosfata) po dveh do štirih tednih zdravljenja, po treh mesecih zdravljenja in zatem vsake tri do šest mesecev pri bolnikih brez dejavnikov tveganja za ledvice.
It is recommended that creatinine clearance is calculated in all patients prior to initiating therapy with tenofovir disoproxil fumarate and renal function (creatinine clearance and serum phosphate) is also monitored after two to four weeks of treatment, after three months of treatment and every three to six months thereafter in patients without renal risk factors.
Pred začetkom zdravljenja z dizoproksiltenofovirijevim fumaratom se priporoča izračun očistka kreatinina pri vseh bolnikih in nadzor delovanja ledvic (očistek kreatinina in koncentracija serumskega fosfata) po dveh do štirih tednih zdravljenja, po treh mesecih zdravljenja in zatem vsake tri do šest mesecev pri bolnikih brez dejavnikov tveganja za ledvice.
It is recommended that Dynastat is used as soon as possible after it is mixed with solvent, although it may be stored if the instructions at the end of the leaflet are strictly followed.
Priporočljivo je, da se pripravljeno raztopino zdravila Dynastat uporabi čimprej po raztapljanju praška z vehiklom; vendar pa se raztopino lahko shranjuje, če se strogo upošteva navodila, ki so navedena na koncu tega navodila.
It is recommended that efavirenz be taken on an empty stomach.
Priporočamo, da se zdravilo Efavirenz jemlje na prazen želodec.
It is recommended that Efavirenz Teva be taken on an empty stomach, preferably at bedtime.
Priporočamo, da se zdravilo Efavirenz Teva jemlje na prazen želodec, po možnosti zvečer pred spanjem.
It is recommended that every time KIOVIG is administered, the name and batch number of the product is recorded.
Vsakič, ko bolniku date zdravilo KIOVIG, zapišite ime in številko serije zdravila.
It is recommended that every time that you use Helixate NexGen, the name and batch number of the product are documented.
Priporočljivo je, da po vsaki uporabi zdravila Helixate NexGen zabeležite ime in številko serije zdravila.
It is recommended that every time that you use Kovaltry, you note down name and batch number of the product.
Priporočljivo je, da po vsaki uporabi zdravila Kovaltry zabeležite ime in številko serije zdravila.
It is recommended that evey time you use BeneFIX, you record the name and batch number of the product.
Priporočljivo je, da ob vsaki uporabi zdravila BeneFIX zabeležite ime in številko serije zdravila.
It is recommended that Gilenya be discontinued if a patient develops macular oedema.
Če pri bolniku pride do makularnega edema, je priporočena prekinitev zdravljenja z zdravilom Gilenya.
It is recommended that haemoglobin concentrations be measured prior to initiation of treatment and tests repeated during treatment as clinically indicated.
Priporočljivo je, da pred uvedbo zdravljenja izmerite koncentracije hemoglobina, nato pa preiskave med zdravljenjem ponavljate, kot je klinično indicirano.
It is recommended that HIV infected women do not breast-feed their infants under any circumstances in order to avoid transmission of HIV.
Priporočljivo je, da ženske okužene z virusom HIV v nobenem primeru ne dojijo in se tako izognejo eni od možnosti za prenos virusa HIVna otroka.
It is recommended that HIV positive women do not breast feed their infants in order to avoid transmission of HIV.
Še več, priporočljivo je, da matere okužene z virusom HIV otrok sploh ne dojijo, saj se tako izognejo eni od možnosti za širjenje virusa HIV.
It is recommended that HIV positive women do not breast feed their infants in order to avoid transmission of HIV.
Še več, priporočljivo je, da matere, okužene z virusom HIV, otrok sploh ne dojijo, saj se tako izognejo eni od možnosti za širjenje virusa HIV.
It is recommended that HIV-infected mothers do not breast-feed their children to exclude the risk of transmission of the virus.
Matere, ki so inficirane z virusom HIV, naj ne dojijo svojih otrok, saj v obratnem primeru obstaja nevarnost prenosa virusa.
It is recommended that HIV-infected women do not breast-feed their infants because there is a possibility that the baby can be infected with HIV through your breast milk.
Priporočeno je, da s HIV okužene ženske ne dojijo, ker se otrok lahko z materinim mlekom okuži s HIV.
It is recommended that HIV-infected women do not breast-feed their infants because there is a possibility that the baby can be infected with HIV through your breast milk.
Priporočeno je, da z virusom HIV okužene ženske ne dojijo, ker se otrok lahko z materinim mlekom okuži z virusom HIV.
It is recommended that HIVinfected women do not breastfeed their infants under any circumstances in order to avoid transmission of HIV.
Priporočeno je, naj ženske okužene z virusom HIV nikakor ne dojijo, da bi se izognile prenosu virusa HIV na novorojenčka.
It is recommended that in patients with thrombocytopenia or bleeding disorders the vaccine be administered subcutaneously (see section 4.4).
Priporočljivo je, da se pri bolnikih s trombocitopenijo ali z motnjami hemostaze cepivo aplicira subkutano (glejte poglavje 4.4).
It is recommended that in patients with thrombocytopenia or bleeding disorders the vaccine be administered subcutaneously (see section 4.4.).
Priporočljivo je, da se pri bolnikih s trombocitopenijo ali z motnjami hemostaze cepivo aplicira subkutano (glejte poglavje 4.4).
It is recommended that individuals who receive a first dose of Silgard complete the vaccination course with Silgard (see section 4.4).
Priporočljivo je, da osebe, ki so prejele prvi odmerek cepiva Silgard, cepljenje dokončajo s cepivom Silgard (glejte poglavje 4.4).
It is recommended that individuals who receive a first dose of Silgard complete the vaccination course with Silgard.
Priporočljivo je, da osebe, ki so prejele prvi odmerek cepiva Silgard, cepljenje dokončajo s cepivom Silgard.
It is recommended that live vaccines not be given concurrently with Inflectra.
Priporočamo, da živih cepiv ne dajete sočasno z zdravilom Inflectra (glejte poglavje 4.4).
It is recommended that live vaccines not be given concurrently with Remsima.
Priporočamo, da živih cepiv ne dajete sočasno z zdravilom Remsima.
It is recommended that MabCampath should be interrupted in patients whose platelet count falls to < 25,000/l or whose absolute neutrophil count (ANC) drops to < 250/l.
Uporabo zdravila MabCampath je priporočljivo prekiniti pri bolnikih, ki se jim število trombocitov zmanjša na < 25.000/l ali jim absolutno število nevtrofilcev (ANC - absolute neutrophil count) pade na < 250/l.
It is recommended that Moventig is taken in the morning, for patient convenience to avoid bowel movements in the middle of the night.
Priporočljivo je, da bolniki zdravilo Moventig vzamejo zjutraj, da se izognejo odvajanju blata sredi noči.
It is recommended that newborns of women exposed to mercaptopurine during pregnancy are monitored for haematological and immune system disturbances.
Priporoča se, da se pri novorojenčkih mater, ki so bile med nosečnostjo izpostavljene merkaptopurinu, spremljajo hematološke motnje in motnje imunskega sistema.
It is recommended that no more than three retreatments should be used during a pregnancy.
Priporočljivo je, da se med nosečnostjo ponovno zdravljenje z zdravilom Atosiban SUN ne ponovi več kot trikrat.
It is recommended that no more than three retreatments should be used during a pregnancy.
Priporočljivo je, da se med nosečnostjo ponovno zdravljenje z zdravilom Tractocile ne ponovi več kot trikrat.
It is recommended that paediatric patients, if possible, be brought up to date with all immunisations in agreement with current immunisation guidelines prior to initiating Humira therapy.
Za pediatrične bolnike s poliartikularnim juvenilnim idiopatskim artritisom je priporočljivo, da pred začetkom zdravljenja z zdravilom Humira opravijo vsa cepljenja v skladu z veljavnimi smernicami za cepljenje, če je le mogoče.
It is recommended that paediatric patients, if possible, be brought up to date with all vaccinations in agreement with current vaccination guidelines prior to initiating Flixabi therapy.
Priporočamo, da pri pediatričnih bolnikih, če je le mogoče, opravite vsa cepljenja v skladu s trenutno veljavnimi smernicami za cepljenje otrok, preden pri njih uvedete zdravljenje z zdravilom Flixabi.
It is recommended that paediatric patients, if possible, be brought up to date with all vaccinations in agreement with current vaccination guidelines prior to initiating Inflectra therapy.
Priporočamo, da pri pediatričnih bolnikih, če je le mogoče, opravite vsa cepljenja v skladu s trenutno veljavnimi smernicami za cepljenje otrok, preden pri njih uvedete zdravljenje z zdravilom Inflectra.
It is recommended that paediatric patients, if possible, be brought up to date with all vaccinations in agreement with current vaccination guidelines prior to initiating Remicade therapy.
Priporočamo, da pri pediatričnih bolnikih, če je le mogoče, opravite vsa cepljenja v skladu s trenutno veljavnimi smernicami za cepljenje otrok, preden pri njih uvedete zdravljenje z zdravilom Remicade.
It is recommended that paediatric patients, if possible, be brought up to date with all vaccinations in agreement with current vaccination guidelines prior to initiating Remsima therapy.
Priporočamo, da pri pediatričnih bolnikih, če je le mogoče, opravite vsa cepljenja v skladu s trenutno veljavnimi smernicami za cepljenje otrok, preden pri njih uvedete zdravljenje z zdravilom Remsima.
It is recommended that Pandemic influenza vaccine H5N1 MedImmune is not given at the same time as influenza-specific antiviral medicines such as oseltamivir and zanamivir.
Priporočljivo je, da se Cepiva proti pandemski gripi H5N1 MedImmune ne uporabi hkrati s protivirusnimi zdravili, specifičnimi za gripo, kakršni sta na primer oseltamivir in zanamivir.
It is recommended that patients be followed closely for occurrence of clinical respiratory symptoms and patients should be advised to report promptly any new or worsening respiratory symptoms.
Priporočeno je, da bolnike skrbno spremljate glede kliničnih respiratornih simptomov in bolnikom svetujete, naj čim prej poročajo o poslabšanju ali novih respiratornih simpomih.
It is recommended that patients be premedicated to ameliorate the effects of infusion reactions (see section 4.2).
Priporočljiva je premedikacija, da se ublažijo učinki z infuzijo povezanih reakcij (glejte poglavje 4.2).
It is recommended that patients continue treatment with trametinib until patients no longer derive benefit or the development of unacceptable toxicity.
Zdravljenje s trametinibom je priporočljivo nadaljevati, dokler bolniku ne koristi več oziroma dokler se ne pojavijo nesprejemljivi toksični učinki.
It is recommended that patients receive 2 cycles of Bortezomib Hospira following a confirmation of a complete response.
Priporočamo, da bolniki po potrjenem popolnem odgovoru prejmejo še dva kroga zdravljenja z zdravilom Bortezomib Hospira.
It is recommended that patients receive 2 cycles of Bortezomib SUN following a confirmation of a complete response.
Priporočamo, da bolniki po potrjenem popolnem odzivu prejmejo še dva kroga zdravljenja z zdravilom Bortezomib SUN.
It is recommended that patients receive pre-medication with standard doses of dexamethasone (or an equivalent corticosteroid) together with a 5-HT3 antagonist (or other antiemetic) at least 30 minutes prior to ONIVYDE infusion.
Priporoča se, da bolniki prejmejo premedikacijo s standardnimi odmerki deksametazona (ali enakovrednega kortikosteroida), skupaj z antagonistom 5-HT3 (ali drugim antiemetikom), vsaj 30 minut pred infuzijo zdravila ONIVYDE.
It is recommended that patients receiving cladribine should receive irradiated cellular blood components/products to prevent transfusion-related graft-versus-host disease (Ta-GVHD).
Priporočamo, da bolniki, ki prejemajo kladribin, dobivajo obsevane celične krvne sestavine/izdelke, da preprečimo s transfuzijo povezano graft-versus-host bolezen (Ta-GVHD - transfusion associated graft- versus-host disease).
It is recommended that patients receiving leflunomide are not treated with colestyramine or activated powdered charcoal because this leads to a rapid and significant decrease in plasma A771726 (the active metaboliteof leflunomide; see also section 5) concentration.
Bolniki, ki dobivajo leflunomid, naj ne jemljejo holestiramina ali aktivnega oglja v prahu, ker hitro in pomembno znižata plazemsko koncentracijo A771726 (aktivnega presnovka leflunomida; glejte tudi poglavje 5).
It is recommended that patients treated with substances that are metabolised by the CYP3A enzyme system are to be carefully monitored for two weeks at the start of, or after the end of treatment with rufinamide, or after any marked change in the dose.
Priporočamo, da v začetku in po koncu zdravljenja z rufinamidom ter po vsaki večji spremembi odmerka dva tedna skrbno spremljate bolnike, zdravljene z učinkovinami, ki jih presnavlja encimski sistem CYP3A4.
It is recommended that patients undergo baseline radiographic assessment by lung computed tomography scan or chest radiograph prior to the initiation of Torisel therapy.
Priporočamo, da pri bolnikih pred začetkom zdravljenja z zdravilom Torisel opravite osnovno rentgensko slikanje prsnega koša ali računalniško tomografijo.
It is recommended that Pegasys pre- filled syringes be used for children and adolescents, as they allow for dose adjustments.
Pri otrocih in mladostnikih je priporočljiva uporaba zdravila Pegasys v obliki napolnjenih injekcijskih brizg, saj omogočajo prilagoditev odmerka.
It is recommended that Rapamune be administered 4 hours after ciclosporin (microemulsion).
Priporočeno je dajanje zdravila Rapamune 4 ure po ciklosporinu (mikroemulzija).
It is recommended that Rapamune be used first in combination with ciclosporin and corticosteroids.
Priporočajo, naj se zdravilo Rapamune najprej uporablja skupaj s ciklosporinom in kortikosteroidi.
It is recommended that Rapamune be used with ciclosporin and corticosteroids (other medicines to prevent organ rejection) for two to three months.
Priporočeno je, da se zdravilo Rapamune dva do tri mesece kombinira s ciklosporinom in kortikosteroidi (drugimi zdravili za preprečevanje zavrnitve organov).
It is recommended that renal function (creatinine clearance and serum phosphate) is assessed in all patients prior to initiating therapy with tenofovir disoproxil fumarate and that it is also monitored after two to four weeks of treatment, after three months of treatment and every three to six months thereafter in patients without renal risk factors.
Pred začetkom zdravljenja z dizoproksiltenofovirijevim fumaratom se pri vseh bolnikih priporoča oceno ledvične funkcije (očistek kreatinina in koncentracija serumskega fosfata) in nadzor delovanja ledvic po dveh do štirih tednih zdravljenja, po treh mesecih zdravljenja in zatem vsake tri do šest mesecev pri bolnikih brez dejavnikov tveganja za ledvice.
It is recommended that Senshio should be taken with food at the same time each day.
Jemanje zdravila Senshio se priporoča skupaj s hrano in vsaj dan ob istem času.
It is recommended that serum ferritin be monitored every month.
Vrednost feritina v serumu je priporočljivo spremljati vsak mesec.
It is recommended that sirolimus whole blood trough levels be closely monitored in patients with impaired hepatic function (see Therapeutic monitoring of the medicinal product and dose adjustment).
Pri bolnikih z jetrno okvaro se priporoča skrbno spremljanje najnižje koncentracije sirolimusa v stanju dinamičnega ravnovesja v polni krvi (glejte Terapevtsko spremljanje koncentracije zdravila in prilagajanje odmerka).
It is recommended that SIRTURO is administered by directly observed therapy (DOT).
Priporočeno je odmerjanje zdravila SIRTURO v okviru neposredno nadzorovanega zdravljenja (DOT directly observed therapy).
It is recommended that Starlix be administered prior to meals.
Priporočljivo je jemanje zdravila Starlix pred obroki.
It is recommended that Stocrin be taken on an empty stomach and without food, preferably at bedtime.
Priporočljivo je, da se jemlje na prazen želodec in brez hrane, po možnosti pred spanjem.